Heart Cell Polyploidy Blocks Cardiac Regeneration in Mammals

Heart regeneration remains one of medicine's greatest challenges, and new research reveals that cellular polyploidy may be a key barrier. This comprehensive review examines how cardiomyocytes—the heart's muscle cells—develop multiple copies of chromosomes during development, fundamentally altering their regenerative capacity.

The study reveals that mammalian cardiomyocytes start as diploid cells during embryonic development but lose their ability to complete cell division and become polyploid as they mature. This contrasts sharply with lower vertebrates like zebrafish, which maintain regenerative capacity throughout life. The degree, timing, and mechanisms of this polyploidization vary dramatically between mammalian species, including humans.

Critically, recent research has established that polyploidy creates a significant barrier to cardiomyocyte proliferation and heart regeneration following cardiac injury. When heart cells become polyploid, they essentially lose their ability to divide and replace damaged tissue, limiting the heart's natural repair mechanisms.

The review synthesizes current understanding of how cardiomyocyte-intrinsic factors, external cellular signals, and environmental conditions regulate this polyploidization process. This knowledge could inform new therapeutic approaches that either prevent polyploidization or reverse it to restore regenerative capacity.

These findings have profound implications for treating heart disease, the leading cause of death globally. By understanding why mammalian hearts lose regenerative ability while other vertebrates retain it, researchers may develop strategies to reactivate cardiac regeneration in humans.